Prescription drug · ANDA
Rivastigmine Tartrate NDC 62332-065
Rivastigmine tartrate 4.5 mg/1 · Capsule · Oral · Alembic Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62332-065-10 | 62332006510 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (62332-065-10) / 10 CAPSULE in 1 BLISTER PACKMarketed from Jun 12, 2022 | |
| 62332-065-30 | 62332006530 | 30 CAPSULE in 1 BOTTLE (62332-065-30)Marketed from Jun 12, 2022 | |
| 62332-065-60 | 62332006560 | 60 CAPSULE in 1 BOTTLE (62332-065-60)Marketed from Jun 12, 2022 | |
| 62332-065-71 | 62332006571 | 500 CAPSULE in 1 BOTTLE (62332-065-71)Marketed from Jun 12, 2022 | |
| 62332-065-91 | 62332006591 | 1000 CAPSULE in 1 BOTTLE (62332-065-91)Marketed from Jun 12, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Rivastigmine Tartrate
- Generic name (nonproprietary)
- rivastigmine tartrate
- Active ingredients
- Rivastigmine tartrate — 4.5 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Alembic Pharmaceuticals Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 091689
- Marketing start
- Listing expires
- Other FDA classes
- Cholinesterase Inhibitors (Mechanism)
- Identifiers
- Product ID 62332-065_0044f1d7-613c-4611-8481-13032c8cb390SPL ID 0044f1d7-613c-4611-8481-13032c8cb390SPL set ID 0044f1d7-613c-4611-8481-13032c8cb390RxCUI 312835, 312836, 314214, 314215UNII 9IY2357JPEUPC 0362332066308, 0362332063307
- Pharmacologic class
- Cholinesterase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462332006510followed by a unit qualifier and the quantityPackage 62332-0065-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Rivastigmine tartrate capsules are an acetylcholinesterase inhibitor indicated for treatment of: Mild-to-moderate dementia of the Alzheimer’s type (AD) (1.1) Mild-to-moderate dementia associated with Parkinson’s disease (PD) (1.2) 1.1 Alzheimer’s Disease Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). 1.2 Parkinson’s Disease Dementia Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia associated with Parkinson’s disease (PD).
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 091689
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 1.5 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-063 |
| Rivastigmine Tartrate | Rivastigmine tartrate 3 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-064 |
| Rivastigmine Tartrate | Rivastigmine tartrate 4.5 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-065 |
| Rivastigmine Tartrate | Rivastigmine tartrate 6 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-066 |
| Rivastigmine Tartrate | Rivastigmine tartrate 1.5 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-063 |
| Rivastigmine Tartrate | Rivastigmine tartrate 3 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-064 |
| Rivastigmine Tartrate | Rivastigmine tartrate 6 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-066 |